2023 eContouring for Renal SBRT Webinar
To access the Live event on June 27, 2023 at 6 p.m. Eastern time - Click on take course and then navigate past the homework to the Join the Webinar link.
This activity will briefly review the rationale to use radiation therapy to treat kidney cancers, including considerations for patient selection. The main focus will be a comprehensive review of radiation planning, to provide knowledge needed to initiate this treatment in clinical practice including simulation, tumor delineation, motion management and image guidance strategies, dose/fraction considerations and normal tissue sparing constraints.
This webinar was sponsored by the ROI Juan A. del Regato Fund.
This activity is available from June 1, 2023, through 11:59 p.m. Eastern time on May 31, 2025.
This course is designed to meet the interest of radiation oncologists and radiation oncology residents.
Upon completion of this live activity, participants should be able to:
- Develop a radiation therapy plan for kidney cancer, including simulation, tumor delineation, motion management and image guidance strategies, normal tissue constraints, and dose/fractionation considerations.
Shankar Siva, MD is employed by the Peter MacCallum Cancer Centre and has received renumeration from AstraZeneca, Varian Medical Systems and RefleXion Medical Systems. He serves in leadership positions with IASLC and the Radiosurgery Society.
Nick Hardcastle, PhD, is employed by the Peter MacCallum Cancer Center and receives research funding from Varian Medical Systems and RefleXion Medical Systems. He serves in a leadership position with Trans Tasman Radiation Oncology Group.
The person(s) above served as the developer(s) of this activity. Additionally, Education Committee had control over the content of this activity.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $179
- Member: $119
- Member-in-Training: Free
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 2 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.